CS Paper Radar

Interpretable and Steerable Molecular Graph Generation using Concept Bottlenecks

Sarabeshwar Balaji, Ritesh Kumar, Lav R. Varshney

cs.LG ·submitted 2026-10-25 11:45 UTC · v1
published

Abstract

Deep graph generators (DGGs) largely lack interpretability, which is a significant limitation for one of their most crucial applications, drug discovery, where interpretable and transparent generation could provide greater control over the desirability of generated molecules, thereby reducing trial-and-error in candidate selection. Common approaches to interpretability, such as disentanglement, cannot guarantee that the learned representations are human-interpretable. To address this, we propose incorporating concept bottlenecks into DGGs, allowing users to interpret, debug, and steer the generation process. We show that this consistently improves distributional fidelity (lower FCD), with only modest, non-systematic effects on validity and uniqueness. We further explore Concept Controller, an optimization-based steering approach that has proven to be effective for steerable image generation. We evaluate our approach on a one-shot molecular graph generation framework, though the underlying ideas can be transferred to sequential graph generation as well.

Comment
Accepted at AI for Drug Discovery Workshop @ NeurIPS 2026. Additional experiments added

Closest papers

Nearest neighbours by meaning across the whole index.

Conditional GraphGANFed: Optimizing Graph-Structured Molecule Generation in Federated Generative Adversarial Networks

cs.LG cs.DC ·2026-08-24 ·Daniel Manu, Abee Alazzwi
published similarity 0.73
Abstract · 10 pages, 3 figures

Generative adversarial networks (GANs) have garnered considerable attention in molecular discovery for their ability to generate novel and high-quality molecules. To efficiently train a GAN model while preserving data privacy, GraphGANFed has been proposed to incorporate federated learning and graph convolutional networks into GAN. Yet, GraphGANFed cannot produce synthetic molecules that only optimize a user-defined metric(s) to facilitate the new drug discovery process. To address this issue, we introduce a novel extension to GraphGANFed, namely conditional GraphGANFed (cGraphGANFed), by incorporating the critic network to assess generated molecules using user-defined metric(s). The evaluation results from both the critic network and discriminator are integrated into the loss function of the generator, guiding it to generate novel molecules that maintain similar chemical properties to real ones while optimizing user-defined metrics. Extensive simulations are conducted in two scenarios. First, cGraphGANFed endeavors to optimize all seven commonly used metrics, and the results show that cGraphGANFed significantly outperforms GraphGANFed in Validity and LogP, with a slight advantage in QED, across different settings. Second, cGraphGANFed focuses solely on optimizing QED, and the results show that the synthetic molecules produced by cGraphGANFed can achieve more than 10% improvement in QED than GraphGANFed. Also, the results demonstrate cGraphGANFed has enhanced resilience against mode collapses and performance reduction caused by non-IID data.

0.26

Latent Flow Matching for Molecular Graph Generation

cs.LG cs.AI ·2026-10-05 ·Mathis Goupillon, Roman Bresson, Konstantinos Divriotis, Michalis Vazirgiannis
similarity 0.72
Abstract

Modern graph generative models typically operate directly in the discrete graph space, explicitly generating node and edge variables, which can become costly as graphs grow. In this paper, we perform generation explicitly on latent representations of entire graphs obtained from a pretrained Variational Autoencoder with high reconstruction fidelity. The generated representations, obtained through flow matching, are then decoded only at the final step. Across molecular benchmarks of increasing size, our approach achieves strong validity and FCD while offering a favorable quality-efficiency trade-off compared with state-of-the-art explicit graph generative models. One of the main advantages of this formulation is that the graph representation only needs to be learned once, after which the same one can be reused across multiple generative objectives without retraining. We demonstrate generation guided by molecular properties and further introduce validity-aware generation though a classifier learned directly in latent space. All code will be made available upon acceptance.

0.21

Controllable Molecule Generation via Sparse Representation Editing: An Interpretability-Driven Perspective

cs.LG ·2026-11-06 ·Zhuoran Li, Xu Sun, Chang Wen Chen, Wanyu Lin
code/data similarity 0.71
Abstract

Controllable molecule generation is crucial for diverse scientific applications, such as drug discovery and materials design. While large language models (LLMs) show great promise, their dense and entangled representations impede precise control over the generation of molecules with bespoke substructures or properties. To address this, we propose Sparse Representation Editing (SpaRE), an interpretability-driven framework for fine-grained and precise control in LLM-based molecule generation. The crux of SpaRE is to learn an overcomplete sparse feature space that disentangles LLM representations into a compact set of latent features corresponding to chemically meaningful concepts. Within this space, we can directly manipulate these concept-aligned latent features to achieve (1) local control, by generating target atoms and functional groups at specified positions; and (2) global control, by customizing the overall structural and physicochemical properties within defined ranges. In this way, our framework advances interpretability from post-hoc analysis to actionable generative control. Experiments show that SpaRE can generate chemically desirable molecules under complex constraints in real-world scenarios, while offering mechanistic insights for quantitative structure-property analysis. The code and demo are available at https://github.com/WanyuGroup/ICML2026_SpaRE.

0.38

A Systematic Evaluation of Molecule Generation Models for De Novo Drug Design: From Benchmarks to Practical Insights

cs.LG ·2026-09-09 ·Xinrui Xu, Xueer Wang, Dan Luo, Sisi Yuan, Xuan Lin
publishedbenchmarkcode/data similarity 0.68
Abstract · This document is the unedited Author's version of a Submitted Manuscript subsequently accepted for publication in [Journal of Chemical Infor…

Molecule generation has emerged as a powerful computational tool for de novo drug design, enabling the exploration of chemical space beyond the limits of conventional virtual screening. The field has progressed rapidly, driven by advances in molecular representations, generative architectures, and target-aware modeling strategies. However, existing reviews typically address specific model families or application scenarios in isolation, rather than offering an integrated perspective on how these components collectively form a coherent generation workflow. In this review, we present a comprehensive evaluation of molecule generation models for de novo drug design, covering 82 methods across five deep generative frameworks, including recurrent neural network (RNN)- and Transformer-based models, variational autoencoders (VAEs), generative adversarial networks (GANs), flow-based models, and diffusion models. We first summarize widely used benchmarks and molecular representations, and then examine the methodological principles underlying both general and pocket-conditioned generation. A central contribution of this work is a systematic synthesis and comparative analysis of reported performance across commonly used benchmarks and evaluation metrics. We also summarize representative experimentally validated case studies. Looking ahead, we discuss future directions in standardized 3D data, interaction-aware generation, receptor flexibility, and multi-objective molecular design, with the aim of improving the reliability and experimental relevance of molecule generation. All collected benchmark resources, evaluation metrics, and model references are provided in a publicly accessible repository at https://github.com/JacklinGroup/molecule-generation-review.

0.31

MolLedger: An Additive Graph Neural Network with Chemically Grounded ADME Attributions

cs.LG ·2026-08-31 ·Christina X. Ji
theory similarity 0.68
Abstract

Optimizing absorption, distribution, metabolism, and excretion (ADME) is an important part of small molecule drug discovery. Many machine learning models have been built to predict ADME properties to facilitate this optimization process, but explaining model predictions is challenging. We propose a new graph neural network architecture with built-in atom attributions. Our model MolLedger learns a global context vector for each molecule and a per-atom head to output atom scores that sum to the predicted property. The atom scores are regularized to align with relevant chemical properties. We prove that MolLedger is a universal approximator and demonstrate empirically that the new architecture obtains explainability with little effect on performance. We show that the interpretations from MolLedger are faithful, concordant with held-out physical properties, and align with the changes between matched molecular pairs. Our case studies comparing interpretations from multiple methods on molecular pairs reveal that MolLedger is much better at producing sensible explanations for predicted property changes.

0.25

Navigating Route Latent Space for Synthesizable Molecular Design

cs.AI cs.CE ·2026-10-06 ·Tao Li, Tuan Vinh, Monika Raj, Yuan Fang, Zhichun Guo +1 more
position similarity 0.67
Abstract

Goal-directed molecular design has advanced rapidly, yet a substantial proportion of designed molecules remain difficult to synthesize in practice, limiting their real-world utility. Prior synthesizability-aware methods either project generated molecules back to synthesizable analogs that deviate from the intended target, or optimize directly in discrete synthesis spaces that lack a continuous landscape for efficient search. We argue that this limitation mainly comes from the search space rather than the optimizer. To address this, we propose RouteFlow, a framework that reformulates synthesizable molecular design as a search over a continuous route latent space, where each latent maps back to a complete synthesis route and synthesizability is inherently preserved. To navigate this space, we adopt reward-guided flow matching as an efficient sampler that steers toward high-property regions. Since reward optimization may push latents off the manifold of real synthesis routes, where decoding becomes unreliable, we further introduce a cycle-consistency mechanism to stabilize fine-tuning. Across 16 optimization tasks from Therapeutic Data Commons, RouteFlow achieves the best sample efficiency among synthesizability-aware baselines, with the best synthetic accessibility and the highest retrosynthesis success rate. Our results also confirm that the proposed cycle-consistency reliably keeps optimization on-manifold while improving target properties, supporting effective synthesizable molecular discovery.

0.17

Benchmarking graph-based models for in-silico toxicity prediction in drug discovery

cs.LG q-bio.BMq-bio.QM ·2026-09-29 ·Noel Suarez-Barro, Manuel Lama, Juan C. Vidal
code/data similarity 0.67
Abstract

Drug discovery is a costly and high-risk process, where toxicity-related failures remain a major cause of attrition in both preclinical and clinical stages. As a result, accurate early prediction of chemical toxicity is essential to reduce downstream costs and improve compound prioritization. In this context, graph deep learning (GDL) has emerged as a powerful paradigm for toxicity prediction, leveraging molecular graph representations to learn directly from chemical structure with improved expressivity over traditional approaches. Despite the growing number of proposed models, current literature-based comparisons are often difficult to interpret due to inconsistencies in datasets, preprocessing pipelines, and evaluation protocols. To address this limitation, we introduce a unified and standardized benchmarking framework for GDL-based toxicity prediction. We systematically evaluate more than 20 representative approaches under consistent experimental conditions and across multiple datasets and partitioning strategies, enabling a fair and reproducible comparison of model performance. In addition, we complement this empirical study with a structured literature analysis to contextualize existing methodological trends and performance claims. Our results provide a clearer and more reliable assessment of the current state of the field, highlighting both the strengths and limitations of existing graph-based approaches. To support transparency and reproducibility, we release our benchmarking framework as open-source software https://gitlab.citius.gal/noel.suarez/benchtox, allowing the community to evaluate and compare models under consistent conditions.

0.24

DrugReason: Dynamic Multi-View Reasoning over Knowledge Graph and Language Evidence for Drug Repurposing

cs.LG cs.AI ·2026-09-06 ·Zijie Liu, Hongxuan Li, Zhen Tan, Jinhao Duan, Baixiang Huang +3 more
top venuecode/data similarity 0.66
Abstract · EMNLP 2026 Main Conference Code: https://github.com/jesseliu0913/DrugReason

Drug repurposing aims to identify new therapeutic uses for existing compounds and, compared with de novo drug discovery, offers a faster and more cost-effective path to clinical translation. However, the space of candidate drug-disease pairs is enormous and their underlying relationships often depend on complex multi-hop biological mechanisms, making it difficult to reliably predict which pairs represent true therapeutic relationships. Existing approaches tackle this from two directions: knowledge graph-based methods organize curated biomedical evidence into structured relational networks for grounded multi-hop reasoning, while LLM-based methods leverage pretrained knowledge to generate flexible mechanistic rationales. Yet neither is sufficient alone - KGs are confined to observed graph structure while LLMs lack factual grounding and risk hallucination. To address this gap, we propose DrugReason, a multi-view reasoning framework that integrates grounded KG reasoning with LLM-generated mechanistic inference for drug repurposing. DrugReason adaptively routes diverse reasoning paths to specialized experts conditioned on the query context, while a cross-expert distillation objective enables knowledge sharing without sacrificing expert specialization. Experiments on PharmaDB, DDInter, and DrugBank show that DrugReason improves average performance over strong single-view reasoning baselines and achieves competitive or superior results compared with graph-based alternatives, while providing interpretable routing-based predictions.

0.53